1. Profiling gene promoter occupancy of Sox2 in two phenotypically distinct breast cancer cell subsets using chromatin immunoprecipitation and genome-wide promoter microarrays
   Karen Jung et al, 2014, Breast Cancer Research CrossRef
2. Salinomycin induces apoptosis in cisplatin-resistant colorectal cancer cells by accumulation of reactive oxygen species
   Jin Zhou et al, 2013, Toxicology Letters CrossRef
3. CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations
   Roxana S Redis et al, 2013, Oncotarget CrossRef
4. Cancer stem cells and their implication in breast cancer
   E. Carrasco et al, 2014, European Journal of Clinical Investigation CrossRef
5. Breast cancer patient‐derived scaffolds as a tool to monitor chemotherapy responses in human tumor microenvironments
   Maria Carmen Leiva et al, 2021, Journal of Cellular Physiology CrossRef
6. In Vitro Employment of Recombinant Taenia solium Calreticulin as a Novel Strategy Against Breast and Ovarian Cancer Stem-like Cells
   Alejandro Schcolnik-Cabrera et al, 2020, Archives of Medical Research CrossRef
7. SOX2 functions as a molecular rheostat to control the growth, tumorigenicity and drug responses of pancreatic ductal adenocarcinoma cells
   Erin L. Wuebben et al, 2016, Oncotarget CrossRef
8. Effect of long noncoding RNA CCAT2 on drug sensitivity to 5‐fluorouracil of breast cancer cells through microRNA‐145 meditated by p53
   Ziyun Zhang et al, 2022, Journal of Biochemical and Molecular Toxicology CrossRef
9. Silencing long non-coding RNA HNF1A-AS1 inhibits growth and resistance to TAM of breast cancer cells via the microRNA-363/SERTAD3 axis
   Ying Li et al, 2021, Journal of Drug Targeting CrossRef
10. Reactive gliosis in the adult zebrafish retina
    Jennifer L. Thomas et al, 2016, Experimental Eye Research CrossRef
11. Novel merosesquiterpene exerts a potent antitumor activity against breast cancer cells in vitro and in vivo
    Esther Carrasco et al, 2014, European Journal of Medicinal Chemistry CrossRef